rational
patient
develop
acut
respiratori
distress
syndrom
ard
infect
sever
respiratori
virus
eg
sever
acut
respiratori
syndromecoronaviru
avian
influenza
viru
exhibit
unusu
high
level
belong
nonelr
glutamicleucinearginin
cxc
chemokin
superfamili
may
bystand
sever
viru
infect
may
directli
contribut
pathogenesi
neutrophilmedi
excess
pulmonari
inflamm
object
investig
contribut
receptor
axi
pathogenesi
ard
nonvir
viral
origin
method
induc
nonvir
ard
acid
aspir
viral
ard
intratrach
influenza
viru
infect
wildtyp
mice
mice
defici
ifnab
receptor
tir
domaincontain
adaptor
induc
ifnb
trif
measur
main
result
found
mice
lack
demonstr
improv
sever
surviv
nonvir
viral
ard
wherea
mice
lack
control
sever
ard
vivo
increas
level
lung
ard
origin
larg
extent
infiltr
pulmonari
neutrophil
express
uniqu
receptor
via
trif
act
autocrin
fashion
oxid
burst
chemotaxi
inflam
neutrophil
lead
fulmin
pulmonari
inflamm
conclus
signal
appear
critic
factor
exacerb
patholog
ard
thu
axi
could
repres
prime
therapeut
target
treatment
acut
phase
ard
nonvir
viral
origin
natur
histori
ard
mark
exud
acut
prolif
subacut
fibrot
late
phase
mani
patient
die
acut
fulmin
phase
ard
character
extrem
sever
pulmonari
inflammatori
respons
accompani
massiv
neutrophil
accumul
increas
vascular
permeabl
high
product
cytokin
chemokin
ie
socal
cytokin
storm
date
effect
drug
target
underli
pathophysiolog
proven
improv
clinic
outcom
ard
high
lethal
threat
emerg
respiratori
viru
infect
import
identifi
novel
therapeut
target
ard
patient
infect
sar
coronaviru
avian
influenza
develop
ard
exhibit
unusu
high
level
cxc
motif
chemokin
also
known
ifnginduc
protein
kd
bind
receptor
induc
chemotaxi
apoptosi
cell
growth
angiostasi
recent
highli
pathogen
viru
isol
appear
even
potent
induc
compar
less
pathogen
earlier
counterpart
suggest
possibl
impact
increas
level
diseas
sever
howev
previous
believ
higher
level
sequel
viru
infect
increas
activ
jakstat
pathway
whether
contribut
directli
pathogenesi
sever
virusinduc
ard
remain
unclear
hand
rat
homolog
human
increas
nonvir
experiment
lung
injuri
eg
lung
injuri
rat
although
precis
mechan
remain
unclear
present
studi
hypothes
receptor
activ
particip
pathogenesi
fulmin
phase
viraland
nonviralinduc
ard
data
also
show
mice
defici
receptor
decreas
lung
injuri
sever
increas
surviv
respons
viral
influenza
viru
infect
nonvir
acid
aspir
lung
injuri
although
previous
believ
present
neutrophil
demonstr
presenc
uniqu
neutrophil
popul
express
inflam
lung
mechanist
act
autocrin
fashion
oxid
burst
chemotaxi
inflam
neutrophil
enhanc
fulmin
inflamm
moreov
ifnb
elev
lung
viral
nonvir
lung
injuri
date
controversi
whether
ifnab
contribut
pathogenesi
sever
respiratori
viru
infect
ifnab
receptor
defici
mice
acceler
mortal
result
influenza
viru
sarscoronaviru
infect
examin
ifnab
control
sever
ard
analyz
knockout
ko
mice
use
viral
nonvir
lung
injuri
model
found
mice
protect
sever
lung
injuri
thu
axi
may
prime
therapeut
target
treatment
acut
phase
ard
either
nonvir
viral
origin
studi
approv
local
ethic
committe
turin
itali
studi
patient
ard
age
year
rang
underli
diagnosi
sepsi
n
bone
marrow
bm
transplant
n
pneumonia
n
multipl
trauma
n
ventil
vt
mlkg
bodi
weight
mean
posit
endexpiratori
pressur
peep
cm
h
patient
extrapulmonari
diseas
requir
mechan
ventil
serv
control
subject
n
bronchoalveolar
lavag
bal
patient
sedat
bronchoscop
guid
lavag
instil
ml
nacl
perform
middl
lobe
aliquot
ml
instil
immedi
reaspir
lavag
fluid
dilut
final
volum
ml
filter
four
layer
gauz
elimin
remain
mucu
sampl
store
aliquot
ml
c
assay
male
spraguedawley
rat
purchas
charl
river
laboratori
wilmington
trif
mutant
mice
previous
describ
mutant
mice
obtain
b
k
univers
grimston
uk
background
trif
mutant
mice
mice
bred
anim
facil
sexand
agematch
mice
use
control
basal
lung
function
lung
structur
compar
among
mice
test
mice
hous
accord
institut
guidelin
anesthet
ketamin
hydrochlorid
mgkgh
xylazin
mgkgh
rat
g
ventil
volumecontrol
constant
flow
inflat
ventil
voltek
enterpris
toronto
canada
carotid
arteri
line
use
measur
arteri
blood
pressur
pd
gould
inc
cleveland
oh
obtain
blood
arteri
blood
gase
cibacorn
model
bayer
leverkusen
germani
lactat
ringer
solut
mlkgh
infus
intraven
intratrach
instil
hcl
ph
mlkg
rat
ventil
hour
fi
peep
cm
h
hour
ventil
left
lung
snap
frozen
liquid
nitrogen
rna
extract
right
lung
fix
buffer
formalin
patholog
examin
control
rat
sacrif
surgic
prepar
without
acid
instil
total
peep
peept
pplateau
pressur
pplat
measur
end
expiratori
inspiratori
occlus
respect
everi
minut
elast
calcul
pplat
peept
vt
use
previous
describ
mous
acid
aspirationinduc
ard
model
similar
rat
model
describ
blockad
studi
mice
anesthet
ketamin
mgkg
xylazin
mgkg
intraperiton
tracheostom
ventil
flexiv
system
scireq
inc
montreal
canada
volum
recruit
maneuv
vrm
perform
standard
volum
histori
measur
made
baselin
intratrach
instil
hcl
ph
mlkg
follow
vrm
mice
ventil
hour
fi
peep
cm
h
salinetr
group
serv
control
use
flexiv
system
lowfrequ
forc
oscil
scireq
inc
measur
airway
elast
well
tissu
elast
mice
input
imped
respiratori
system
zr
measur
frequenc
rang
hz
model
includ
airway
compart
compris
frequencyindepend
airway
inert
constantphas
tissu
compart
compris
coeffici
tissu
elast
fit
zr
allow
partit
lung
function
compon
repres
mechan
properti
airway
lung
tissu
describ
previous
end
experi
left
lung
assess
lung
wetdri
weight
ratio
snap
frozen
liquid
nitrogen
subsequ
biochem
analysi
right
lung
fix
buffer
formalin
histolog
examin
separ
experi
bal
ml
pb
differenti
cell
count
perform
neutral
antibodi
mice
receiv
either
mg
intraperiton
antimous
r
system
inc
minneapoli
mn
isotypematch
control
antibodi
minut
surgic
procedur
acid
instil
mice
random
four
group
control
ab
salin
ab
salin
control
ab
acid
ab
acid
mice
ventil
hour
analyz
describ
mice
anesthet
intraperiton
inject
ketamin
mgkg
xylazin
mgkg
trachea
expos
open
neck
skin
blunt
dissect
intraven
cathet
insert
trachea
mice
receiv
either
suspens
influenza
viru
ld
tcid
ld
tcid
ml
phosphatebuff
salin
pb
volum
pb
intratrach
cathet
mice
monitor
daili
weigh
everi
hour
infect
separ
experi
respiratori
function
analyz
day
infect
use
flexiv
system
scireq
inc
brief
mice
anesthet
intraperiton
inject
ketamin
mgkg
xylazin
mgkg
tracheostom
connect
via
endotrach
cannula
ventil
flexiv
scireq
inc
mice
ventil
rate
breathsmin
vt
mlkg
measur
airway
elast
well
tissu
elast
mice
day
infect
influenza
viru
mock
control
describ
obtain
istituto
zooprofilattico
sperimental
dell
venezi
padova
itali
strain
isol
character
accord
european
guidelin
cec
briefli
viru
inocul
specif
pathogenfre
embryon
fowl
egg
allanto
rout
hemagglutin
allanto
fluid
collect
egg
isol
viru
inactiv
use
bpropiolacton
viru
inactiv
confirm
reinocul
two
blind
passag
virus
serotyp
confirm
specif
influenza
subtyp
vivo
acut
lung
injuri
ali
experi
control
wildtyp
wt
ko
mice
surgic
prepar
ventil
volumecontrol
constant
flow
inflat
ventil
voltek
enterpris
toronto
canada
describ
inactiv
viru
particl
mg
rna
control
vehicl
instil
intratrach
follow
vrm
cm
h
mice
ventil
hour
fi
peep
cm
h
peept
pplat
measur
end
expiratori
inspiratori
occlus
respect
everi
minut
airway
elast
calcul
pplat
peept
vt
tcid
assay
aliquot
cultur
supernat
tissu
lysat
serial
dilut
dulbecco
modifi
eagl
medium
appli
quadrupl
mdck
cellswel
plate
incub
c
hour
inoculum
remov
cell
wash
pb
suppli
dulbecco
modifi
eagl
medium
contain
bovin
serum
albumin
trypsin
mgml
third
day
infect
tcid
determin
basi
karber
method
focusform
unit
assay
immunofluorescencebas
titrat
assay
conduct
describ
previous
briefli
mdck
cell
plate
cellswel
plate
asahi
techno
glass
hour
infect
serial
dilut
supernat
tissu
lysat
contain
viru
cell
fix
paraformaldehyd
pb
contain
triton
wash
pb
three
time
antibodi
react
common
sequenc
avian
influenza
viru
nucleoprotein
np
matrix
protein
use
primari
antibodi
detect
viral
antigen
antibodi
bind
viral
protein
detect
alexa
fluor
secondari
antibodi
molecular
probe
carlsbad
ca
dilut
pb
contain
bovin
serum
albumin
bm
transplant
perform
mice
describ
brief
recipi
mice
irradi
rad
bone
flush
rpmi
life
technolog
grand
island
ny
fetal
calf
serum
atlanta
biolog
norcross
ga
femur
tibia
steril
condit
harvest
bm
cell
ml
media
deliv
intraven
tail
vein
recipi
mous
recipi
mice
hous
barrier
facil
individu
ventil
cage
highenergi
particul
arrest
filterfilt
air
pathogenfre
condit
bm
transplant
recipi
chimera
use
experi
week
transplant
acidaspirationinduc
ali
model
rat
total
rna
isol
rat
lung
tissu
hour
use
rneasi
mini
kit
qiagen
valencia
ca
pool
rna
hybrid
affymetrix
santa
clara
ca
rat
genechip
duplic
analysi
differenti
gene
express
affymetrix
chip
perform
use
r
packag
bioconductor
raw
cel
file
normal
rma
method
affi
packag
influenza
virusinduc
ali
model
mice
total
rna
extract
lung
tissu
mice
treat
influenza
viru
influenza
group
mockinfect
mice
control
pb
group
hour
infect
hybrid
illumina
mous
genechip
calcul
log
foldchang
moder
statist
accomplish
use
limma
packag
kegg
pathway
enrich
analysi
use
david
bioinformat
resourc
nih
blood
sampl
obtain
left
ventricl
pa
measur
cibacorn
model
bayer
assess
arteri
blood
oxygen
indic
respiratori
failur
pulmonari
edema
assess
measur
lung
wetdri
weight
ratio
previous
describ
brief
lobe
lung
clean
weigh
obtain
wet
weight
place
oven
c
hour
measur
dri
weight
ratio
wet
weight
dri
weight
calcul
bal
perform
describ
total
cell
number
count
cell
type
differenti
bal
smear
stain
diffquick
method
fisher
scientif
inc
waltham
neutrophil
count
express
percentag
neutrophil
multipli
total
number
cell
bal
fluid
sampl
lung
tissu
fix
buffer
formalin
process
histolog
analysi
hematoxylin
eosin
immunohistochemistri
immunohistochemistri
rabbit
antimous
polyclon
antibodi
r
system
inc
use
immunofluoresc
stain
lung
tissu
approxim
frozen
lung
section
prepar
optim
cut
temperatur
compoundembed
lung
tissu
tissu
section
stain
use
goat
antimous
ab
r
system
inc
antigoat
ab
invitrogen
carlsbad
ca
rat
ab
bd
san
jose
ca
antirat
alexa
ab
invitrogen
immunofluoresc
stain
cell
bal
fluid
bal
smear
stain
use
biotinyl
antimous
ab
ebiosci
san
diego
ca
avidin
ab
invitrogen
rat
ab
bd
antrat
alexa
ab
invitrogen
nuclei
stain
invitrogen
imag
visual
use
confoc
microscop
nikon
tokyo
japan
lung
tissu
cell
prepar
previous
describ
brief
lung
tissu
excis
mice
fine
minc
tissu
piec
place
medium
contain
uml
collagenas
mgml
dnase
incub
remain
intact
tissu
disrupt
passag
cell
strainer
digest
cell
suspens
layer
ficol
centrifug
g
minut
macrophag
neutrophil
layer
collect
bmderiv
neutrophil
isol
healthi
wt
mice
use
naiv
neutrophil
control
mice
kill
femur
hind
leg
remov
distal
tip
edg
cut
bm
cell
isol
flush
femur
hank
balanc
salt
solut
cell
pellet
resuspend
layer
ficol
centrifug
g
minut
neutrophil
layer
collect
identif
puriti
isol
bone
marrowderiv
neutrophil
stain
ab
examin
flow
cytometr
analysi
bm
neutrophil
isol
wt
ko
mice
describ
isol
neutrophil
ml
media
inject
intratrach
ko
mice
thirti
minut
neutrophil
transfer
recipi
ko
mice
subject
acid
aspirationinduc
lung
injuri
model
describ
frozen
lung
tissu
homogen
cell
lysi
buffer
supernat
assay
use
specif
elisa
kit
detect
murin
r
system
inc
human
plasma
lung
lavag
fluid
cultur
supernat
human
cell
assay
use
specif
elisa
kit
human
r
system
inc
myeloperoxidas
mpo
activ
assay
report
previous
briefli
lung
tissu
homogen
sonic
mmoll
potassium
phosphat
buffer
contain
hexadecyltrimethylammonium
bromid
ethylenediaminetetraacet
acid
centrifug
supernat
incub
potassium
phosphat
buffer
contain
substrat
h
odianisidin
dihydrochlorid
sigma
aldrich
st
loui
mo
enzymat
activ
determin
spectrometr
valu
repres
chang
odmin
per
gram
tissu
weight
measur
influenza
viru
np
cellular
rna
perform
realtim
polymeras
chain
reaction
pcr
analysi
protocol
describ
briefli
rna
extract
cell
use
rneasi
mini
kit
qiagen
firststrand
cdna
synthes
dnafre
rna
use
takara
reversetranscript
reagent
sampl
firststrand
cdna
subject
realtim
pcr
quantif
thermal
cycler
takara
tokyo
japan
use
forward
revers
primer
indic
rna
glyceraldehyd
dehydrogenas
invari
control
rel
amount
mrna
calcul
use
compar
threshold
cycl
c
method
examin
express
cell
bal
fluid
bmderiv
naiv
neutrophil
stain
antibodi
r
system
inc
level
cell
analyz
facscalibur
bd
data
analyz
flowjo
softwar
tree
star
ashland
isotyp
control
use
sampl
superoxid
product
measur
use
isoluminol
assay
plate
greiner
bioon
monro
nc
accord
manufactur
instruct
cell
krh
incub
mm
isoluminol
tokyo
kasei
kogyo
tokyo
japan
uml
horseradish
peroxidas
sigma
minut
c
nformylmethionylleucylphenylalanin
fmlp
mm
nm
phorbol
myrist
acet
ad
reaction
mixtur
via
inject
port
spectramax
l
micropl
reader
molecular
devic
sunnyval
ca
light
emiss
record
fix
time
interv
bm
neutrophil
isol
wt
mice
describ
infect
influenza
viru
moi
mock
hour
chemotaxi
neutrophil
toward
assay
use
cytoselect
cell
migrat
assay
kit
accord
manufactur
assay
protocol
cell
biolab
san
diego
ca
briefli
influenza
virusor
mocktreat
neutrophil
allow
migrat
toward
ngml
hour
presenc
absenc
ngml
migratori
cell
quantifi
cyquant
gr
dye
data
shown
mean
sem
measur
singl
time
point
analyz
unpair
test
analysi
varianc
twotail
test
time
cours
analyz
repeat
measur
mix
model
analysi
varianc
bonferroni
post
test
logrank
test
perform
kaplanmei
surviv
curv
statist
test
calcul
use
graphpad
prism
program
p
less
consid
indic
statist
signific
examin
gene
express
profil
nonvir
lung
injuri
perform
microarray
analysi
use
acid
aspirationinduc
lung
injuri
model
rat
recapitul
acut
phase
human
ard
intratrach
instil
hydrochlor
acid
produc
increas
pulmonari
elast
repres
chang
pressur
achiev
per
unit
chang
volum
figur
decreas
arteri
partial
pressur
oxygen
pa
hour
figur
pa
co
mean
arteri
blood
pressur
remain
rel
constant
see
figur
onlin
supplement
histolog
analysi
reveal
inflammatori
cell
infiltr
alveolar
hemorrhag
hyalin
membran
format
acidtr
lung
hour
figur
number
neutrophil
lung
lavag
fluid
markedli
elev
acidtr
anim
hour
figur
total
rna
extract
lung
tissu
rat
treat
acid
acid
group
rat
without
acid
instil
control
group
hybrid
affymetrix
rat
genechip
quantil
normal
differenti
express
determin
use
r
statist
packag
microarray
analysi
bioconductor
packag
total
gene
significantli
chang
acid
aspir
hour
figur
summar
gene
upregul
fivefold
acid
aspirationinduc
lung
injuri
strongli
upregul
gene
cytokineschemokin
includ
kc
also
highli
upregul
acidtr
lung
function
enrich
analysi
identifi
cytokinecytokin
receptor
interact
cytokin
signal
top
kegg
pathway
overrepres
among
differenti
express
gene
acid
aspir
figur
next
use
mous
model
acid
aspirationinduc
lung
injuri
confirm
upregul
mrna
figur
upper
panel
protein
figur
lower
panel
lung
quantit
realtim
pcr
elisa
respect
acid
aspir
result
rapid
impair
lung
function
wt
mice
figur
figur
histolog
chang
hemorrhag
inflammatori
cell
infiltr
hyalin
membran
format
figur
addit
mrna
ifnb
upregul
acidtr
lung
figur
next
determin
whether
find
relev
patient
nonvir
ard
compar
control
patient
extrapulmonari
diseas
patient
acutephas
ard
nonvir
origin
high
level
plasma
bal
fluid
irrespect
ard
etiolog
four
patient
sepsi
two
bm
transplant
three
pneumonia
one
multipl
trauma
figur
data
indic
increas
acut
phase
nonvir
ard
figur
mrna
viru
np
protein
lung
increas
infect
figur
day
infect
influenza
viru
mock
control
measur
tissu
elast
figur
airway
elast
figur
mice
repres
mechan
properti
lung
tissu
airway
respect
pulmonari
function
becom
impair
time
viral
infect
model
figur
figur
histolog
inflammatori
cell
increas
day
alveolar
wall
thicken
pulmonari
edema
hemorrhag
inflammatori
cell
infiltr
found
day
infect
virusinfect
lung
figur
neutrophil
number
markedli
elev
virusinfect
lung
day
figur
thu
figur
summar
result
show
gene
upregul
fivefold
induct
lung
injuri
strongli
upregul
gene
pathway
enrich
analysi
identifi
enrich
tolllik
receptor
signal
cytokinecytokin
receptor
interact
kegg
pathway
among
gene
found
upregul
viralinduc
lung
injuri
figur
upregul
mrna
lung
virustr
mice
confirm
quantit
realtim
pcr
figur
similar
nonvir
lung
injuri
mrna
express
ifnb
upregul
virustr
lung
figur
data
indic
increas
acut
phase
viral
lung
injuryard
next
examin
whether
delet
receptor
control
sever
nonvir
lung
injuri
mice
acid
aspir
result
rapid
impair
lung
function
wt
mice
demonstr
increas
pulmonari
tissu
elast
figur
edema
format
assess
wet
dri
weight
figur
histolog
chang
hemorrhag
inflammatori
cell
infiltr
figur
comparison
ko
mice
exhibit
better
pulmonari
function
figur
less
edema
format
figur
fewer
histolog
chang
figur
defici
also
result
diminish
pulmonari
neutrophil
sequestr
demonstr
lower
neutrophil
count
bal
fluid
figur
mpo
hemoprotein
abundantli
express
neutrophil
secret
activ
thu
mpo
activ
use
indic
neutrophil
activ
compar
acidtr
wt
mice
mpo
activ
reduc
lung
acidtr
ko
mice
figur
product
potent
neutrophil
chemoattract
figur
also
reduc
lung
acidtr
ko
mice
moreov
neutral
specif
antibodi
improv
pulmonari
function
figur
decreas
pulmonari
edema
format
figur
neutrophil
infiltr
lung
figur
similar
ko
mice
ko
mice
show
improv
lung
function
figur
histolog
chang
figur
acidtr
lung
neutrophil
count
bal
fluid
acid
treatment
less
ko
mice
compar
wt
mice
figur
type
ifn
also
upregul
acidtr
lung
wt
mice
figur
next
test
whether
type
ifn
involv
pathogenesi
acid
aspirationinduc
lung
injuri
use
ko
mice
chang
lung
function
acid
aspir
compar
ko
mice
wt
mice
figur
neutrophil
count
bal
fluid
acid
treatment
differ
ko
mice
wt
mice
figur
data
suggest
type
ifn
unlik
involv
patholog
acid
aspirationinduc
lung
injuri
mice
next
determin
whether
delet
could
control
sever
influenza
virusinduc
lung
injuri
mice
use
live
influenza
viru
figur
test
whether
defici
could
improv
sever
influenza
virusinduc
lung
injuri
compar
wt
mice
ko
figur
figur
differ
ko
wt
mice
data
indic
delet
markedli
improv
sever
viral
lung
injuri
determin
impact
defici
pulmonari
inflamm
independ
viru
replic
use
inactiv
influenza
virusmedi
mous
lung
injuri
model
previous
describ
bolu
intratrach
instil
inactiv
influenza
viru
caus
rapid
impair
lung
function
ie
increas
elast
figur
edema
format
figur
ko
mice
treat
viru
show
improv
elast
figur
histolog
sign
lung
injuri
figur
keep
protect
effect
mpo
activ
figur
level
figur
pulmonari
edema
format
figur
decreas
mice
challeng
viru
data
suggest
delet
improv
sever
influenza
virusinduc
lung
injuri
like
independ
viru
replic
examin
cell
type
respons
lung
injuri
conduct
experi
use
bm
chimera
transfer
ko
bm
wt
mice
transfer
ko
bm
ko
recipi
significantli
improv
lung
function
figur
reduc
pulmonari
mpo
activ
figur
level
figur
acid
aspirationinduc
lung
injuri
model
convers
transfer
wt
type
bm
ko
host
markedli
enhanc
sever
lung
injuri
compar
mice
mutat
bm
cell
figur
note
signific
differ
lung
function
transfer
wt
bm
ko
mice
transfer
ko
bm
wt
mice
data
indic
hematopoiet
cell
includ
macrophag
neutrophil
control
sever
lung
injuri
next
sought
identifi
cell
type
produc
lung
lung
injuryard
use
immunohistochemistri
found
abund
cell
acidtr
lung
hour
figur
right
upper
panel
influenza
virusinfect
lung
day
infect
figur
right
lower
panel
appear
macrophag
neutrophil
moreov
mrna
express
significantli
elev
neutrophil
isol
lung
mice
treat
acid
hour
figur
left
panel
infect
influenza
virus
day
figur
right
panel
previou
studi
shown
express
polymorphonuclear
neutrophil
macrophag
isol
acidor
virustr
lung
also
express
lower
rate
figur
data
suggest
larg
produc
fulmin
phase
neutrophil
naiv
neutrophil
nonvir
viral
lung
injuri
remark
nonelr
motif
cxc
chemokin
ifnb
larg
produc
macrophag
rather
neutrophil
injur
lung
figur
contrast
larg
produc
neutrophil
injur
lung
figur
previous
report
bind
gproteincoupl
receptor
known
express
activ
lymphocyt
natur
killer
nk
cell
epitheli
endotheli
cell
previous
believ
present
naiv
neutrophil
howev
recent
studi
shown
express
neutrophil
patient
chronic
lung
diseas
healthi
control
subject
thu
next
test
whether
present
inflam
neutrophil
lung
fulmin
injuri
mrna
significantli
upregul
neutrophil
lung
obtain
mice
treat
acid
hour
figur
upper
panel
influenza
viru
infect
day
figur
lower
panel
wherea
almost
absent
naiv
neutrophil
lung
obtain
control
mice
figur
also
protein
map
neutrophil
bal
cell
obtain
influenza
virusinfect
mice
figur
lower
panel
bmderiv
naiv
neutrophil
figur
upper
panel
moreov
flow
cytometr
analysi
demonstr
express
higher
bal
neutrophil
obtain
influenza
viru
infectedmic
bmderiv
naiv
neutrophil
figur
previous
demonstr
tolllik
receptor
trif
axi
repres
common
pathway
respons
lung
injuri
therefor
investig
whether
trif
involv
induct
inflam
neutrophil
shown
figur
express
induc
inflam
neutrophil
isol
virusinfect
wt
mice
abolish
neutrophil
isol
virusinfect
trif
ko
mice
furthermor
express
flow
cytometr
analysi
less
bal
neutrophil
obtain
virusinfect
trif
ko
mice
virusinfect
wt
mice
figur
data
suggest
infiltr
neutrophil
lung
ard
noninfiltr
naiv
neutrophil
express
via
trif
pathway
data
indic
induct
origin
neutrophil
uniqu
neutrophil
popul
express
fulmin
lung
injuri
prompt
us
examin
possibl
autocrin
loop
neutrophil
describ
test
whether
activ
neutrophil
autocrin
fashion
examin
effect
fmlpinduc
oxid
burst
neutrophil
isol
acidtr
versu
control
lung
found
treatment
enhanc
fmlpinduc
superoxid
gener
neutrophil
isol
acidtr
figur
right
panel
control
figur
left
panel
lung
similar
oxid
burst
figur
chemotaxi
activ
toward
enhanc
neutrophil
isol
acidtr
control
lung
figur
inflam
neutrophil
express
figur
data
suggest
enhanc
oxid
burst
well
chemotaxi
inflam
naiv
neutrophil
autocrin
fashion
lung
injuri
final
examin
whether
axi
neutrophil
control
sever
lung
injuri
vivo
perform
neutrophil
adopt
transfer
experi
mice
neutrophil
isol
wt
ko
mice
adopt
transfer
ko
mice
mice
subject
acid
aspirationinduc
lung
injuri
model
compar
transfer
ko
neutrophil
ko
mice
transfer
wt
neutrophil
ko
mice
significantli
impair
pulmonari
function
assess
pulmonari
tissu
elast
figur
total
respiratori
system
elast
figur
similarli
acid
aspir
transfer
wt
neutrophil
nontreat
ko
mice
significantli
impair
pulmonari
function
assess
pulmonari
tissu
elast
figur
total
respiratori
system
elast
figur
data
suggest
inflam
neutrophil
particip
pathogenesi
lung
injuri
vivo
belong
nonelr
cxc
chemokin
superfamili
lack
normal
gluleuarg
tripeptid
sequenc
adjac
cxc
motif
nonelr
cxc
chemokin
believ
chemoattract
cell
nk
cell
neutrophil
report
play
role
tcell
nkcellmedi
diseas
multipl
sclerosi
asthma
allograft
reject
fibrosi
figur
activ
oxid
burst
chemotaxi
inflam
neutrophil
superoxid
gener
naiv
left
panel
inflam
right
panel
neutrophil
isol
lung
tissu
obtain
control
acidtr
mice
respect
enhanc
formylmethionylleucylphenylalanin
fmlp
induc
superoxid
gener
inflam
naiv
neutrophil
three
independ
experi
done
b
chemotact
activ
toward
neutrophil
isol
lung
tissu
obtain
control
acidtr
lung
injuri
mice
enhanc
chemotaxi
acidtr
lung
injuri
naiv
neutrophil
p
compar
acidtr
neutrophil
without
treatment
c
neutrophil
isol
lung
obtain
wildtyp
wt
knockout
ko
mice
hour
acid
treatment
isol
neutrophil
intratrach
inject
lung
ko
mice
mice
subject
acid
aspirationinduc
lung
injuri
model
hour
chang
tissu
elast
acid
treatment
ko
mice
intratrach
transplant
wt
neutrophil
wt
ko
ko
mice
receiv
ko
neutrophil
ko
ko
shown
n
group
p
whole
time
cours
compar
wt
ko
ko
ko
neutrophil
isol
lung
obtain
wt
ko
mice
hour
acid
treatment
isol
neutrophil
intratrach
inject
lung
ko
mice
mice
subject
acid
aspirationinduc
lung
injuri
model
hour
chang
tissu
elast
acid
treatment
ko
mice
intratrach
transplant
wt
neutrophil
wt
ko
ko
mice
receiv
ko
neutrophil
ko
ko
shown
n
group
p
whole
time
cours
compar
wt
ko
ko
ko
e
scheme
show
postul
mechan
involv
neutrophilmedi
sever
pulmonari
inflamm
scheme
base
function
analysi
report
paper
see
discuss
detail
data
bd
present
mean
sem
surpris
increas
level
lung
lung
injuri
origin
larg
extent
infiltr
pulmonari
neutrophil
express
uniqu
receptor
addit
act
autocrin
fashion
oxid
burst
chemotaxi
inflam
neutrophil
lead
fulmin
pulmonari
inflamm
figur
thu
apart
possibl
biomark
appear
critic
factor
exacerb
initi
inflammatori
respons
may
thu
respons
untoward
effect
inflamm
caus
lung
injuri
previous
demonstr
activ
pathway
damageassoci
molecular
pattern
deriv
die
cell
common
signal
pathway
respons
pathogenesi
lethal
lung
injuri
caus
multipl
nonvir
ie
acid
aspir
viral
ie
sar
influenza
anthrax
stimuli
interestingli
key
chemokin
downstream
pathway
also
produc
lung
stimul
either
ligand
demonstr
critic
involv
pathogenesi
acut
phase
nonvir
viral
lung
injuryard
also
show
neutrophil
popul
express
receptor
via
trif
inflam
lung
loss
associ
improv
surviv
respons
influenza
viru
infect
mice
accord
find
antagonist
result
mild
reduct
diseas
symptom
ferret
protect
influenzainfect
mice
mortal
clinic
cours
pathophysiolog
featur
ard
mark
three
phase
exud
acut
prolif
subacut
fibrot
late
patient
ard
surviv
exud
phase
enter
fibrot
phase
may
requir
longterm
ventil
support
andor
supplementari
oxygen
alveolar
edema
inflammatori
exud
earlier
phase
convert
extens
alveolar
duct
interstiti
fibrosi
shown
attenu
bleomycininduc
pulmonari
fibrosi
mice
interrupt
angiogenesi
fibroprolifer
data
present
similar
studi
impli
axi
may
dual
role
acut
exud
chronic
fibrot
lung
process
current
therapeut
strategi
acut
fulmin
phase
human
ard
limit
exampl
treatment
pandem
infect
restrict
vaccin
earli
treatment
antivir
agent
oseltamivir
although
antivir
drug
may
benefit
administ
earli
diseas
neither
approach
effect
rescu
patient
alreadi
develop
ard
data
indic
product
bystand
chemokin
sever
respiratori
failur
also
promot
develop
ard
whether
incit
factor
viral
nonvir
origin
thu
axi
repres
interest
therapeut
target
treatment
patient
acut
phase
ard
author
disclosur
avail
text
articl
wwwatsjournalsorg
